- A systematic review of trastuzumab and lapatinib in the treatment of women with brain metastases from HER2-positive breast cancerPia Bükmann Larsen
Department of Oncology, Herlev Hospital, University of Copenhagen, Denmark
Cancer Treat Rev 39:720-7. 2013..The choice of chemotherapy to accompany the blockade is not obvious and we do not know if dual is better than single blockade. Further clinical trials are urgently needed...